BioCardia, Inc. Retained Earnings
BioCardia, Inc. (BCDA) had Retained Earnings of -$172.22 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$172.22M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$170.61M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$168.35M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$166.37M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$172.22M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$170.61M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$168.35M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$166.37M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$164.88M 10-Q/A · filed 2025-10-29 | |
| 2025-03-31 | -$162.83M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$160.12M 10-K · filed 2026-03-24 | |
| 2024-09-30 | -$157.82M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$156.09M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$154.44M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$152.18M 10-K · filed 2025-03-26 | -$144.10M 10-Q · filed 2023-05-10 |
| 2023-09-30 | -$150.10M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$147.53M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$144.10M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$140.60M 10-K · filed 2024-03-27 | |
| 2022-09-30 | -$137.58M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$134.52M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $137.60M 10-Q · filed 2022-11-09 | -$132.02M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$128.70M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$125.24M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$122.53M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$119.04M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$116.07M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$113.08M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | -$109.24M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$105.66M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$101.07M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$97.57M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | -$93.78M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$90.03M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$86.36M 10-K · filed 2020-04-09 | |
| 2018-09-30 | -$82.72M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$79.17M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$75.99M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$72.45M 10-K · filed 2019-04-02 | |
| 2017-09-30 | -$68.96M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$65.96M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$63.02M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$60.14M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$6.85M 10-Q · filed 2016-10-17 | |
| 2016-06-30 | -$11.97M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | -$12.05M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$49.83M 10-K · filed 2017-03-30 | -$12.13M 10-K · filed 2016-03-25 |
| 2015-09-30 | -$12.22M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | -$12.30M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$12.38M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | -$12.13M 10-K · filed 2016-03-25 | -$12.45M 10-K · filed 2015-03-24 |
| 2014-09-30 | -$12.52M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$12.56M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | -$12.71M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$12.45M 10-K · filed 2015-03-24 | -$12.71M 10-K · filed 2014-03-24 |
| 2013-09-30 | -$12.71M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | -$12.71M 10-Q · filed 2013-07-26 | |
| 2013-03-31 | -$12.71M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$12.71M 10-K · filed 2014-03-24 | |
| 2012-09-30 | -$12.74M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$13.20M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | -$13.07M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$13.01M 10-K · filed 2013-03-22 | |
| 2011-09-30 | -$12.73M 10-Q · filed 2011-11-15 | |
| 2011-06-30 | -$12.16M 10-Q/A · filed 2011-11-17 | -$11.60M 10-Q · filed 2011-08-11 |
| 2010-12-31 | -$22.67M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |